Elicio Therapeutics, Inc. Finance Lease, Liability, to be Paid, Year Four
Elicio Therapeutics, Inc. (ELTX) had Finance Lease, Liability, to be Paid, Year Four of $31.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour · last filed 2022-03-30
- 2021-12-31: Finance Lease, Liability, to be Paid, Year Four $31.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Four |
|---|---|
| 2021-12-31 | $31.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |